Dr. David Crockett, MD
Claim this profileNebraska Cancer Specialists
Studies Tumors
Studies Solid Tumors
1 reported clinical trial
1 drug studied
Area of expertise
1Tumors
TSC1 positive
TSC2 positive
Stage III
2Solid Tumors
TSC1 positive
TSC2 positive
Stage III
Affiliated Hospitals
More about David Crockett, MD
Clinical Trial Related2 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments David Crockett, MD has experience with
- Nab-sirolimus
Breakdown of trials David Crockett, MD has run
Tumors
Solid Tumors
Metastasis
Cancer
Tuberous Sclerosis Complex
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does David Crockett, MD specialize in?
David Crockett, MD focuses on Tumors and Solid Tumors. In particular, much of their work with Tumors has involved TSC1 positive patients, or patients who are TSC2 positive.
Is David Crockett, MD currently recruiting for clinical trials?
No, David Crockett, MD is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that David Crockett, MD has studied deeply?
Yes, David Crockett, MD has studied treatments such as nab-sirolimus.
What is the best way to schedule an appointment with David Crockett, MD?
Apply for one of the trials that David Crockett, MD is conducting.
What is the office address of David Crockett, MD?
The office of David Crockett, MD is located at: Nebraska Cancer Specialists, Grand Island, Nebraska 68803 United States. This is the address for their practice at the Nebraska Cancer Specialists.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.